An Inhaled PI3Kδ Inhibitor Improves Recovery in Acutely Exacerbating COPD Patients: A Randomized Trial

An Inhaled PI3Kδ Inhibitor Improves Recovery in Acutely Exacerbating COPD Patients: A Randomized Trial

Anthony Cahn,1 J Nicole Hamblin,2 Jon Robertson,3 Malcolm Begg,2 Emily Jarvis,3 Robert Wilson,1 Gordon Dear,4 Claudia Leemereise,5 Yi Cui,6 Maki Mizuma,7 Mickael Montembault,8 Cedric Van Holsbeke,9 Wim Vos,9 Wilfried De Backer,10 Jan De Backer,9 Edith M Hessel2 1Discovery Medicine, GlaxoSmithKline,...

Full description

Bibliographic Details
Main Authors: Cahn A, Hamblin JN, Robertson J, Begg M, Jarvis E, Wilson R, Dear G, Leemereise C, Cui Y, Mizuma M, Montembault M, Van Holsbeke C, Vos W, De Backer W, De Backer J, Hessel EM
Format: Article
Language:English
Published: Dove Medical Press 2021-06-01
Series:International Journal of COPD
Subjects:
acute exacerbation
copd
nemiralisib
Online Access:https://www.dovepress.com/an-inhaled-pi3k-inhibitor-improves-recovery-in-acutely-exacerbating-co-peer-reviewed-fulltext-article-COPD

Internet

https://www.dovepress.com/an-inhaled-pi3k-inhibitor-improves-recovery-in-acutely-exacerbating-co-peer-reviewed-fulltext-article-COPD

Similar Items